Literature DB >> 8158520

Effects of melatonin and the melatonin receptor agonist S-20098 on the vigilance states, EEG spectra, and cortical temperature in the rat.

I Tobler1, K Jaggi, A A Borbély.   

Abstract

The effects of melatonin (3 mg/kg i.p.) and the melatonin receptor agonist S-20098 (3 mg/kg i.p.) on the vigilance states, electroencephalogram power spectra (0.25-25.0 Hz), and cortical temperature were determined in eight rats in the first 6-hr interval of the 12-hr light period. Compared to the vehicle injection both compounds reduced the power density in non-rapid eye movement sleep in the low frequency range (1-8 Hz) but did not affect the vigilance states and brain temperature. The present findings do not indicate that the stimulation of the melatonin receptor exerts a hypnotic effect at doses that had been shown to affect the circadian rest-activity rhythm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158520     DOI: 10.1111/j.1600-079x.1994.tb00078.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

Review 1.  Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.

Authors:  Stefano Comai; Gabriella Gobbi
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

2.  Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light.

Authors:  Jana Tchekalarova; Lidia Kortenska; Natasha Ivanova; Milena Atanasova; Pencho Marinov
Journal:  Psychopharmacology (Berl)       Date:  2019-11-13       Impact factor: 4.530

Review 3.  Sleep timing and the circadian clock in mammals: Past, present and the road ahead.

Authors:  Raymond E A Sanchez; Franck Kalume; Horacio O de la Iglesia
Journal:  Semin Cell Dev Biol       Date:  2021-06-04       Impact factor: 7.499

4.  Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.

Authors:  Simon P Fisher; David Sugden
Journal:  Neurosci Lett       Date:  2009-04-07       Impact factor: 3.046

5.  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

Authors:  Michel Bourin; Elisabeth Mocaër; Roger Porsolt
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

6.  Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms.

Authors:  J R Redman; B Guardiola-Lemaitre; M Brown; P Delagrange; S M Armstrong
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

7.  Seasonal aspects of sleep in the Djungarian hamster.

Authors:  Svitlana Palchykova; Tom Deboer; Irene Tobler
Journal:  BMC Neurosci       Date:  2003-05-19       Impact factor: 3.288

8.  Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.

Authors:  Amandine Descamps; Colette Rousset; Mark J Millan; Mark Millan; Michael Spedding; Philippe Delagrange; Raymond Cespuglio
Journal:  Psychopharmacology (Berl)       Date:  2009-04-16       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.